Analyses / BAC
Dividend-paying mega-cap near 52-week highs; Q2 earnings imminent. Neutral setup.
A free account reveals BAC's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
P/E 13.1x and forward 13.6x trade below historical avg; 1.9% yield provides income floor. 5Y EPS growth 14.3% shows resilience. Near 52-week high ($59.20) but still 30% above YTD lows ($44.75). Q2 earnings catalyst ahead; potential upside if net interest margin holds or loan growth surprises.
▼ Bear Case
Insider selling (273 sells vs 183 buys) signals caution. Price-to-FCF 33x elevated for a bank. Macro headwinds: rate-cut expectations could compress NIM; recession fears weigh on loan demand. P/B 1.32x above long-term tangible book; limited margin of safety. Recent $7.5M SEC settlement and stress-test scrutiny add regulatory drag.
Valuation
fair — score 65/100
P/E 13.1x is attractive vs S&P 500 (~18–20x), and below 15-year avg. P/B 1.32x near book justifies holding but not compelling. Price-to-FCF 33x is high for a bank; signals market skepticism on capital returns or efficiency. Dividend yield 1.9% provides modest income floor.
Technical Levels
Support · $56.00 (Proposed stop-loss) · $57.94 (Today's low / near-term support) · $57.50 (Entry zone floor) · $44.75 (52-week low)
Resistance · $59.20 (52-week high) · $60.00 (Psychological round) · $62.50 (3-month target) · $65.00 (Bull-case ceiling)
Financial Health
Score 71/100. Large-cap bank with stable, profitable operations and strong historical EPS growth. Insider selling outnumbers buying 3:2, a minor red flag. No debt-to-equity or coverage ratios available in payload; assume regulatory capital rules provide safeguard. SEC settlement minor friction. Overall healthy balance sheet typical of systemically important bank.
Catalysts
| Q2 2024 Earnings Report | Next 1–2 weeks (typical late July for large banks) | High. NIM guidance, loan loss provisions, capital return plans will set near-term direction. Beat/miss ±5–8% move likely. |
| Federal Reserve Rate Guidance / Next FOMC Meeting | July–September 2024 | High. Rate-cut timing critical for NIM. Earlier cuts = margin compression. Stability extends multiple. |
| Regulatory / SEC Enforcement Actions | Ongoing | Medium. Recent $7.5M settlement minor; larger penalties could pressure stock. Monitor news. |
| Macroeconomic Data (jobs, inflation, credit spreads) | Monthly / ongoing | Medium-High. Recession signals trigger risk-off; strong data supports loan growth and stability. |
Risk Flags
See BAC's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock BAC free →Recent News
- Bank of America doubles down on Amazon stock after Prime DayYahoo
- Q2 Earnings Season Nears Kickoff: Bank Earnings in FocusYahoo
- Bank Of America (BAC) Faces $7.5 Million SEC Settlement As World Cup Push ExpandsYahoo
- Bank of America Is the Big-Bank Holdout After This Year's Stress Tests. Here's What Its Next Move Could Look Like.Yahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full BAC analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
BAC FAQ
Is BAC a buy right now?
Bank of America Corp's current read is a value setup with 55 confidence over a 3-6 months horizon. Valuation: fair. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is BAC overvalued?
fair (valuation score 65/100). P/E 13.1x is attractive vs S&P 500 (~18–20x), and below 15-year avg. P/B 1.32x near book justifies holding but not compelling. Price-to-FCF 33x is high for a bank; signals market skepticism on capital returns or efficiency. Dividend yield 1.9% provides modest income floor.
What are the risks of buying BAC?
Insider selling (273 sells vs 183 buys) signals caution. Price-to-FCF 33x elevated for a bank. Macro headwinds: rate-cut expectations could compress NIM; recession fears weigh on loan demand. P/B 1.32x above long-term tangible book; limited margin of safety. Recent $7.5M SEC settlement and stress-test scrutiny add regulatory drag.